研究目的
Investigating the therapeutic effects of potential agents against retinal diseases caused by aberrant metabolism of retinoids.
研究成果
The review highlights the potential of retinoid replacement therapy, chemically synthesized regulators, and gene therapy in treating retinal diseases caused by aberrant metabolism of retinoids. It emphasizes the need for further research to optimize these therapeutic strategies for clinical use.
研究不足
The heterogeneity in retinal diseases and the genetic variability among patients may hinder the universal application of gene therapy. The pharmacokinetics and pharmacodynamics of pharmaceutical approaches need further assessment before clinical significance is confirmed.